145 related articles for article (PubMed ID: 7554454)
21. Complement activation in diabetic ketoacidosis and its treatment.
Jerath RS; Burek CL; Hoffman WH; Passmore GG
Clin Immunol; 2005 Jul; 116(1):11-7. PubMed ID: 15925827
[TBL] [Abstract][Full Text] [Related]
22. Complement activation by cellulosic dialysis membranes.
Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
[TBL] [Abstract][Full Text] [Related]
23. Acute reversible hypoxemia in systemic lupus erythematosus.
Abramson SB; Dobro J; Eberle MA; Benton M; Reibman J; Epstein H; Rapoport DM; Belmont HM; Goldring RM
Ann Intern Med; 1991 Jun; 114(11):941-7. PubMed ID: 2024861
[TBL] [Abstract][Full Text] [Related]
24. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.
Wang RH; Phillips G; Medof ME; Mold C
J Clin Invest; 1993 Sep; 92(3):1326-35. PubMed ID: 7690777
[TBL] [Abstract][Full Text] [Related]
25. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
Senaldi G; Makinde VA; Vergani D; Isenberg DA
Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
[TBL] [Abstract][Full Text] [Related]
26. Complement activation before, during and after cardiopulmonary bypass.
Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D
Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017
[TBL] [Abstract][Full Text] [Related]
27. Increased activation of the alternative complement pathway in sickle cell disease.
Chudwin DS; Korenblit AD; Kingzette M; Artrip S; Rao S
Clin Immunol Immunopathol; 1985 Oct; 37(1):93-7. PubMed ID: 3896597
[TBL] [Abstract][Full Text] [Related]
28. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
29. [In-vivo activation of the 4th component of the complement system (C4) in premature and term infants with generalized bacterial infections].
Nürnberger W; Stannigel H; Müntel V; Michelmann I; Wahn V; Göbel U
Klin Padiatr; 1990; 202(3):141-6. PubMed ID: 2355716
[TBL] [Abstract][Full Text] [Related]
30. [Complement and serum immunoglobulins in homozygous and heterozygous sickle cell anemia in Senegal].
Dieye TN; Ndiaye O; Ndiaye AB; Thiam D; Fall-Seck K; Diop S; Diop BM; Fall M; Diakhaté L
Dakar Med; 1999; 44(2):175-9. PubMed ID: 11957280
[TBL] [Abstract][Full Text] [Related]
31. The synthesis of a water soluble complement activating polyacrylic acid-IgG polymer.
Schmer G; Henderson RA; Müller W
J Biomater Sci Polym Ed; 1994; 6(1):67-78. PubMed ID: 7947474
[TBL] [Abstract][Full Text] [Related]
32. Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement.
Buyon JP; Tamerius J; Belmont HM; Abramson SB
Arthritis Rheum; 1992 Sep; 35(9):1028-37. PubMed ID: 1418018
[TBL] [Abstract][Full Text] [Related]
33. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
Freysdottir J; Sigfusson A
J Immunol Methods; 1991 Aug; 142(1):45-52. PubMed ID: 1833467
[TBL] [Abstract][Full Text] [Related]
34. [The relationship between complement C3 receptors (CR1, CR3) on polymorphonuclear leukocytes and complement fragments during hemodialysis].
Ueda M; Deguchi M; Takemura S; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):679-84. PubMed ID: 1749118
[TBL] [Abstract][Full Text] [Related]
35. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
Buyon JP; Tamerius J; Ordorica S; Young B; Abramson SB
Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
[TBL] [Abstract][Full Text] [Related]
36. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
37. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
Hara N; Abe M; Inuzuka S; Kawarada Y; Shigematsu N
Chest; 1992 Oct; 102(4):1060-4. PubMed ID: 1395743
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the activation pathways of the complement in psoriatic patients by use of complement fragment C4d and Bb measurements.
Takematsu H; Tagami H
Dermatologica; 1989; 179 Suppl 1():16-9. PubMed ID: 2789155
[TBL] [Abstract][Full Text] [Related]
39. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
[TBL] [Abstract][Full Text] [Related]
40. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
